The urokinase receptor is a major vitronectin-binding protein on endothelial cells

Experimental Cell Research
Sandip M KanseKlaus T Preissner

Abstract

We have previously demonstrated that vitronectin (VN), a morphoregulatory protein in the vessel wall, is internalized and translocated to the subendothelial matrix by an integrin-independent mechanism (J. Histochem. Cytochem. 41, 1823-1832, 1993). The cell surface component which mediates the initial contact of VN with endothelial cells is defined here. The specific binding of VN to endothelial cells demonstrated the following properties: a threefold increase after phorbol ester treatment; 85% inhibition by pretreatment of cells with phosphatidylinositol-phospholipase C to release glycolipid-anchored surface proteins; a 90% inhibition by urokinase (u-PA) receptor blocking antibody. u-PA increased VN binding to cells due to an eightfold increase in the affinity of VN for the u-PA receptor. Structure-function studies showed that the amino-terminal fragment of u-PA, devoid of any proteolytic activity, mediated this effect. Active plasminogen activator inhibitor-1 (PAI-1), but not inactivated PAI-1, inhibited VN binding to cells and displaced VN that was prebound to endothelial cell monolayers. Similarly, VN binding to purified (immobilized) u-PA receptor, but not to integrin, was enhanced by u-PA and inhibited by PAI-1. Hence, the...Continue Reading

Citations

Oct 12, 2010·International Journal of Colorectal Disease·Petra KrauseIngo Leister
Sep 6, 2001·The Biochemical Journal·G Høyer-HansenN Behrendt
Jan 19, 2002·Differentiation; Research in Biological Diversity·F ElfmanG Cunha
Mar 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Natalya V BelkinaStephen Shaw
Sep 22, 1998·The Journal of Experimental Medicine·A E MayK T Preissner
Jan 15, 1997·European Journal of Biochemistry·G Høyer-HansenK Danø
Nov 30, 2005·Molecular and Cellular Biology·Gilles BuchwalterBohdan Wasylyk
Apr 4, 2002·Biological Chemistry·Susan FongSteven Rosenberg
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Erika GeimonenErich R Mackow
Apr 17, 2009·Canadian Journal of Physiology and Pharmacology·Vsevolod A TkachukYelena V Parfyonova
Jan 24, 2003·Expert Opinion on Therapeutic Targets·Steven Rosenberg
Oct 29, 2000·Cell Adhesion and Communication·S A Wilcox-AdelmanP J McKeown-Longo
Aug 7, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Helena EnocssonChristopher Sjöwall
May 1, 1997·Kidney International·P Pintavorn, B J Ballermann
Aug 11, 2010·Biochemical and Biophysical Research Communications·Ahmed H MekkawyMohammad H Pourgholami
Mar 9, 2007·Matrix Biology : Journal of the International Society for Matrix Biology·Roman M SalasznykPaula J McKeown-Longo
Nov 5, 2003·Medicinal Research Reviews·Charles Edo de Bock, Yao Wang
May 13, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Haakon SkogsethJostein Halgunset

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.